Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol sedation for painless induced abortion
ChiCTR2000037526Phase 3Not yet recruiting
- Sponsor
- Jingzhou First People's Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remimazolam in procedural pain (2 arms), sponsored by Jingzhou First People's Hospital. Primary endpoints: Hemodynamic and respiratory stability during sedation, MOAA/S score during operation and 3 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2000037526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037526.